Dantrolene is a medication used to treat and prevent malignant hyperthermia, a rare and potentially fatal reaction to certain anesthetic agents [1]. It is also prescribed to manage spasticity associated with chronic conditions such as multiple sclerosis, cerebral palsy, and spinal cord injuries [1][2]. Dantrolene works by reducing calcium ion release from the sarcoplasmic reticulum within muscle cells, thereby relaxing muscles [3].
How Does Dantrolene Work in Malignant Hyperthermia?
During malignant hyperthermia, uncontrolled calcium release leads to sustained muscle contraction, increased metabolism, and a rapid rise in body temperature [3]. Dantrolene intervenes by inhibiting the ryanodine receptor, which is responsible for calcium release in skeletal muscle. By blocking this receptor, dantrolene decreases the excessive influx of calcium ions, which in turn mitigates the hypermetabolic state and prevents the severe symptoms of malignant hyperthermia [3][4].
What Are the Uses for Dantrolene Beyond Anesthesia?
Beyond its critical role in treating and preventing malignant hyperthermia, dantrolene is prescribed to alleviate muscle spasticity. This condition, characterized by stiff muscles and involuntary muscle spasms, can be a debilitating symptom of various neurological disorders. Dantrolene's muscle-relaxant properties help to reduce this spasticity, improving a patient's ability to move and function [1][2].
What Are the Potential Side Effects of Dantrolene?
Common side effects associated with dantrolene use include drowsiness, dizziness, weakness, diarrhea, and nausea [1]. More serious side effects, though less common, can include liver damage, particularly with long-term use. Patients are advised to report any unusual symptoms to their healthcare provider [1][5].
When Does Dantrolene's Patent Protection End?
Information regarding specific patent expiry dates for dantrolene is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patent lifecycles [6]. Understanding patent expirations is crucial for predicting when generic versions of a drug may become available, potentially impacting market pricing and accessibility.